Dazcapistat, CAS [[2221010-42-8]]

Product Overview

• Article Name: Dazcapistat, CAS [[2221010-42-8]]
• Biozol Catalog Number: MCE-HY-132850
• Supplier Catalog Number: HY-132850
• Alternative Catalog Number: MCE-HY-132850-50MG,MCE-HY-132850-100MG,MCE-HY-132850-10MMX1ML,MCE-HY-132850-10MG,MCE-HY-132850-5MG,MCE-HY-132850-25MG
• Manufacturer: MedchemExpress
• Category: Biochemikalien
• Alternative Names: BLD-2660

Product Description

Dazcapistat (BLD-2660) is an orally active small-molecule inhibitor of calpain 1, 2, and 9 (calpain 1, 2, 9). Dazcapistat reduces the expression/production level of IL-6 in injured lung tissue and alleviates fibrosis. Dazcapistat exerts anti-fibrotic effects in various animal models of fibrosis in the skin, liver and lung. Dazcapistat can be used in research related to coronavirus disease 2019 (COVID-19) and idiopathic pulmonary fibrosis[1][2].

Product Properties

• Molecular Weight: 395.38
• Purity: 98
• CAS Number: [2221010-42-8]
• Formula: C21H18FN3O4
• Target: Proteasome

Application Notes

• Application Notes: MCE Product type: Reference compound